Evidence map›Paper›PMID 26020269›Full record

ArticlePloS one2015

Abbreviated exposure to hypoxia is sufficient to induce CNS dysmyelination, modulate spinal motor neuron composition, and impair motor development in neonatal mice.

Jens O Watzlawik, Robert J Kahoud, Ryan J O'Toole, Katherine A M White, Alyssa R Ogden, Meghan M Painter, Bharath Wootla, Louisa M Papke, Aleksandar Denic, Jill M Weimer and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Widespread tissue hypoxia dysregulates cell and metabolic pathways in SMA.Annals of clinical and translational neurology · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Jens O WatzlawikDepartment of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America.
Robert J KahoudDepartment of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America; Department of Pediatric and Adolescent Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America.
Ryan J O'TooleChildren's Health Research Center, Sanford Research, Sioux Falls, South Dakota, United States of America.
Katherine A M WhiteChildren's Health Research Center, Sanford Research, Sioux Falls, South Dakota, United States of America.
Alyssa R OgdenChildren's Health Research Center, Sanford Research, Sioux Falls, South Dakota, United States of America.
Meghan M PainterDepartment of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America.
Bharath WootlaDepartment of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America.
Louisa M PapkeDepartment of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America.
Aleksandar DenicDepartment of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America.
Jill M WeimerChildren's Health Research Center, Sanford Research, Sioux Falls, South Dakota, United States of America.
William A CareyDepartment of Pediatric and Adolescent Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America.
Moses RodriguezDepartment of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America.
Mayo Clinic · USSanford Research · US

Funding

Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
Yeast 2 HybridP20GM103620 · NIGMS · SANFORD RESEARCH/USD · PI ROUX, KYLE J · 2013 to 2023
$24.2M
The Impact of PD-1 Inhibition on Immune-Response to ChemoradiotherapyP20GM103548 · NIGMS · SANFORD RESEARCH/USD · PI MISKIMINS, W KEITH · 2012 to 2020
$20.8M
Novel mechanisms for distal transport in developing and mature neuronsR01NS082283 · NINDS · SANFORD RESEARCH/USD · PI WEIMER, JILL M · 2014 to 2018
$1.9M
Nanopore Biosensor for Kinetics of Reparative Antibodies on Plasma MembranesR01GM092993 · NIGMS · UNIVERSITY OF MINNESOTA · PI OH, SANG-HYUN · 2010 to 2013
$1.6M
Genetic Analysis of Spontaneous RemyelinationR01NS048357 · NINDS · MAYO CLINIC ROCHESTER · PI BIEBER, ALLAN JAMES · 2008 to 2011
$1.0M
Clinical Translation of a Neuron Protective Recombinant Human AntibodyR21NS073684 · NINDS · MAYO CLINIC ROCHESTER · PI RODRIGUEZ, MOSES · 2011 to 2012
$434k
NCATS NIH HHS UL1 TR000135NIGMS NIH HHS P20 GM103548NIGMS NIH HHS P20 GM103620NIGMS NIH HHS R01 GM092993NINDS NIH HHS 5R01NS082283-02NINDS NIH HHS R01 NS048357NINDS NIH HHS R01 NS082283NINDS NIH HHS R21 NS073684
6 · The paper itself

Abstract

Neonatal white matter injury (nWMI) is an increasingly common cause of cerebral palsy that results predominantly from hypoxic injury to progenitor cells including those of the oligodendrocyte lineage. Existing mouse models of nWMI utilize prolonged periods of hypoxia during the neonatal period, require complex cross-fostering and exhibit poor growth and high mortality rates. Abnormal CNS myelin composition serves as the major explanation for persistent neuro-motor deficits. Here we developed a simplified model of nWMI with low mortality rates and improved growth without cross-fostering. Neonatal mice are exposed to low oxygen from postnatal day (P) 3 to P7, which roughly corresponds to the period of human brain development between gestational weeks 32 and 36. CNS hypomyelination is detectable for 2-3 weeks post injury and strongly correlates with levels of body and brain weight loss. Immediately following hypoxia treatment, cell death was evident in multiple brain regions, most notably in superficial and deep cortical layers as well as the subventricular zone progenitor compartment. PDGFαR, Nkx2.2, and Olig2 positive oligodendrocyte progenitor cell were significantly reduced until postnatal day 27. In addition to CNS dysmyelination we identified a novel pathological marker for adult hypoxic animals that strongly correlates with life-long neuro-motor deficits. Mice reared under hypoxia reveal an abnormal spinal neuron composition with increased small and medium diameter axons and decreased large diameter axons in thoracic lateral and anterior funiculi. Differences were particularly pronounced in white matter motor tracts left and right of the anterior median fissure. Our findings suggest that 4 days of exposure to hypoxia are sufficient to induce experimental nWMI in CD1 mice, thus providing a model to test new therapeutics. Pathological hallmarks of this model include early cell death, decreased OPCs and hypomyelination in early postnatal life, followed by dysmyelination, abnormal spinal neuron composition, and neuro-motor deficits in adulthood.

Indexed as

AnimalsAnimals, NewbornDisease Models, AnimalHomeobox Protein Nkx-2.2Homeodomain ProteinsHumansHypoxia-Ischemia, BrainMiceMotor NeuronsMyelin SheathNerve Tissue ProteinsNeural Stem CellsNuclear ProteinsOligodendrogliaTranscription FactorsWhite MatterHomeobox Protein Nkx-2.2Homeodomain ProteinsNerve Tissue ProteinsNKX2-2 protein, humanNkx2-2 protein, mouseNuclear ProteinsTranscription Factors

Identifiers

PMID26020269
PMCPMC4447462
OpenAlexW754512578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.